The Leadership Team at BioTheryX is responsible for guiding the company's strategic vision and direction, particularly in the development of innovative therapies for hematological malignancies. Comprising key executives such as the CEO, CMO, and VP of Biology, this team oversees clinical development, operational execution, and ensures alignment with regulatory requirements while fostering cross-functional collaboration to drive business growth and scientific advancement.